Abstract
Metal radiotracers exhibit beneficial properties that can improve in vivo positron emission tomography (PET) imaging over traditional radionuclides, such as longer half-lives, facile last-stage radiolabeling steps, and the potential for dual imaging-therapy applications. Among such radionuclides, 64Cu exhibits a longer half-life (t1/2 = 12.7 h) that allows for later PET imaging times and the ability to distribute 64Cu imaging agents to facilities that do not have an on-site cyclotron. Herein, we report a 64Cu PET imaging agent that shows appreciable in vivo brain uptake and exhibits high specific affinity for beta-amyloid aggregates, leading to the successful PET imaging of amyloid plaques in the brains of 5xFAD mice versus those of wild-type mice.Herein, we report a 64Cu positron emission tomography (PET) imaging agent that shows appreciable in vivo brain uptake and exhibits high specific affinity for beta-amyloid (Aβ) aggregates, leading to the successful PET imaging of amyloid plaques in the brains of 5xFAD mice versus those of wild-type mice. The employed approach uses a bifunctional chelator with two Aβ-interacting fragments that dramatically improves the Aβ-binding affinity and lipophilicity for favorable bloodtextendashbrain barrier penetration, while the use of optimized-length spacers between the Cu-chelating group and the Aβ-interacting fragments further improves the in vivo Aβ-binding specificity and brain uptake of the corresponding 64Cu PET imaging agent.
Original language | English (US) |
---|---|
Pages (from-to) | 30928-30933 |
Number of pages | 6 |
Journal | Proceedings of the National Academy of Sciences |
Volume | 117 |
Issue number | 49 |
DOIs | |
State | Published - Dec 8 2020 |
Keywords
- Alzheimer’s disease
- multivalent effect
- (Aβ) peptide
- amyloid beta
- blood–brain barrier
- positron emission tomography imaging
- Blood-brain barrier
- Multivalent effect
- Amyloid beta (Aβ) peptide
- Alzheimer's disease
- Positron emission tomography imaging
ASJC Scopus subject areas
- General